-
High sensitivity CRP may Predict Psoriatic Arthritis in Psoriasis Patients, suggests research
14 Apr 2025 19:24 GMT
… Information on patient demographics, psoriasis features, medications and musculoskeletal symptoms … development of Psoriatic Arthritis in Psoriasis: A prospective cohort study … CRP, Predict, Psoriatic, Arthritis, Psoriasis Patients, suggests, research, Eder L …
-
Women with Psoriasis More Likely to Discontinue Biologics Than Men, Study Finds
14 Apr 2025 21:15 GMT
… related drug survival.”
In psoriasis and psoriatic arthritis, … outcomes in patients with psoriasis. To assess sex- … researchers investigated changes in Psoriasis Area and Severity Index … Dutch BioCAPTURE registry. J Psoriasis Psoriatic Arthritis. Published …
-
Psoriasis Market Outlook in the 7MM Through 2034: In-Depth Analysis by Psoriasis Type | DelveInsight
14 Apr 2025 17:00 GMT
… different types of psoriasis including Plaque Psoriasis, Generalized Pustular Psoriasis, Mild to Moderate … Plaque Psoriasis, and Moderate to Severe Psoriasis …
-
Weekly review: Strong plaque psoriasis data, our April issue, and more
14 Apr 2025 14:19 GMT
… with moderate-to-severe plaque psoriasis. In the ICONIC-LEAD trial …
-
Significance of Icotrokinra Findings for Adolescents with Psoriasis, with Lawrence Eichenfield, MD
14 Apr 2025 14:11 GMT
… living with moderate-to-severe psoriasis given once-daily treatment with … ,” Eichenfield explained. “Certainly for adolescent psoriasis with this particular drug, in …
-
Childhood maltreatment linked to higher risk of rheumatoid arthritis and psoriasis, study finds
14 Apr 2025 14:08 GMT
… —specifically, rheumatoid arthritis and psoriasis. The association was particularly … that includes rheumatoid arthritis, psoriasis, multiple sclerosis, and inflammatory … immune disorders: rheumatoid arthritis, psoriasis, coeliac disease, multiple sclerosis, …
-
Johnson & Johnson’s Oral IL-23, Icotrokinra, Poised to Redefine the Psoriasis Treatment Landscape Following Positive Phase 3 Data, According to Spherix Global Insights
14 Apr 2025 14:05 GMT
… to reshape the current psoriasis treatment algorithm. Data from … Insights’ RealTime Dynamix™: Plaque Psoriasis (US) Q1 2025 … unmet need for treating psoriasis. Moreover, most dermatologists … ultimate impact on the psoriasis landscape. Spherix continues …
-
Adherence in Psoriasis Care: Barriers, Solutions, and the Road Ahead
14 Apr 2025 13:26 GMT
-
Aditxt Subsidiary Adimune Announces Positive Results from Mayo Clinic Pre-Clinical Studies to Support FDA and European Regulatory Submissions for Type 1 Diabetes, Psoriasis, and Stiff Person Syndrome Human Trials
14 Apr 2025 12:55 GMT
… involved in Type 1 Diabetes, Psoriasis, and certain CNS autoimmune disorders …
-
Notable Attributes of Icotrokinra for Adolescents with Psoriasis, with Lawrence Eichenfield, MD
13 Apr 2025 19:57 GMT
… adolescents with moderate-to-severe psoriasis treated with once-daily icotrokinra … know that in pediatric psoriasis or adolescent psoriasis, something that's … highest level efficacy medications for psoriasis were injectables.”
Eichenfield highlighted that …
About
© 1995-2025